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SUMMARY
The CASTOR (CST) transcription factor was initially identified for its role in maintaining stem cell
competence in the Drosophila dorsal midline. Here we report that Xenopus CST affects
cardiogenesis. In CST-depleted embryos, cardiomyocytes at the ventral midline arrest and are
maintained as cardiac progenitors, while cells in more dorsal regions of the heart undergo their normal
program of differentiation. Cardia bifida results from failed midline differentiation, even though
cardiac cell migration and initial cell fate specification occur normally. Our fate mapping studies
reveal that this ventral midline population of cardiomyocytes ultimately gives rise to the outer
curvature of the heart; however, CST-depleted midline cells overproliferate and remain a coherent
population of nonintegrated cells positioned on the outer wall of the ventricle. These midline-specific
requirements for CST suggest the regulation of cardiomyocyte differentiation is regionalized along
a dorsal-ventral axis and that this patterning occurs prior to heart tube formation.
INTRODUCTION
Terminal differentiation of progenitor populations is initiated in response to alterations in
growth factor signaling, which leads to an arrest in cell cycle progression and the transcription
of tissue-specific genes. In contrast to other cell types such as neural tissue and skeletal muscle,
relatively little is known about the molecular pathways that trigger the onset of cardiomyocyte
differentiation during heart development. Studies in tissue culture focusing on the ability of
growth factors to drive the formation of cardiomyocytes from stem cells have identified
numerous pathways that may be involved in cardiomyocyte differentiation (Guan and
Hasenfuss, 2007; Liu et al., 2007); however, the transcriptional targets of these pathways or
the endogenous role for their components during in vivo embryonic cardiomyocyte
differentiation remains unclear. Furthermore, it is not known whether cardiomyocytes
differentiate in a uniform manner in response to a single cue or if specific subsets of
cardiomyocytes differentiate in response to different pathways.
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To address these issues and to begin to identify the molecular pathways that function in vivo
to regulate the onset of cardiomyocyte differentiation, we have characterized the Xenopus
ortholog of Castor (Cst), a protein that regulates stem cell competence in Drosophila (Cui and
Doe, 1992; Mellerick et al., 1992). In this report, we show that vertebrate Cst is expressed in
the myocardial layer of the heart in a dorsal-to-ventral gradient and demonstrate that CST is
required within a subset of cardiac progenitor cells for the initiation of cardiomyocyte
differentiation at the ventral midline. Fate mapping of cardiac tissue indicates that cardiac
progenitors at the ventral midline have a specific cell fate, giving rise to a population of cells
in the outer curvature of the ventricle. In contrast, ventral midline cells depleted of CST
overproliferate and fail to integrate into cardiac muscle. Collectively, these studies demonstrate
that CST is required for the proper timing of differentiation within a subset of cardiac
progenitors that are fated to give rise to the outer curvature of the ventricle, and suggest that
regulation of cardiomyocyte differentiation is regionalized along a dorsal-ventral axis prior to
heart tube formation.
RESULTS
Cst Is Expressed in the Myocardium Prior to the Onset of Cardiomyocyte Differentiation
To begin to identify the molecular pathways that are involved in the decisions of cardiac
progenitor cells to proliferate or differentiate, we have focused on the vertebrate orthologs of
Castor (Cst), a known regulator of stem cell competence in Drosophila. We have identified
two alternatively 5-prime-spliced variants of vertebrate Castor (Cstα and Cstβ) from Xenopus
laevis (X. laevis) as well as Xenopus tropicalis (X. tropicalis) (Figure 1A; see Figure S1A in
the Supplemental Data available with this article online). Synteny and sequence analysis
confirmed that these are the true orthologs of jawed vertebrate and Drosophila Castor (Figures
S1B–S1D). In vitro translation of CSTα and CSTβ give proteins of the expected size (Figure
S1E) and injection of mRNAs into Xenopus show CSTα and CSTβ both localize to the nucleus
in Xenopus tissue (Figures S1F–S1G). RT-PCR analysis with Cstα- and Cstβ-specific primers
(Figure S2A) indicate Cstα is expressed at the onset of neurulation (Stage 13), whereas Cstβ
is expressed slightly later (Stage 15), with both transcripts continuing to be expressed
throughout embryonic development. Using a probe common to Cstα and Cstβ shows a nearly
identical spatial pattern of expression in X. laevis and X. tropicalis (Figure 1B; Figures S2B–
S2K and S3), with Cst expression first observed at the dorsal midline in the developing
hindbrain region of the embryo (Figure S2B) (Stage 13) and by early tailbud stage in the
developing somites (Figure 1B). By early tailbud stage (Stage 27) we also observe expression
of Cst in the heart primordium (Figure 1B) during the period when the bilateral heart fields
begin to fuse across the ventral midline, and at Stage 29 we find Cst coexpressed with the
cardiac maker Nkx2.5 throughout the heart tube (Figures 1B–1C; Figure S4). On more detailed
analysis, we observe Cst expression within the myocardial layer of the heart in a dorsal-to-
ventral gradient (Figure 1D). We further note that onset and maintenance of Cst expression is
not disrupted in TBX5-, TBX20-, or HSP27-depleted embryos (Brown et al., 2005, 2007),
suggesting that CST is not a downstream component of these pathways (data not shown).
CST Is Required for Heart Development
To determine the requirement for CST in development, both CSTα and CSTβ were depleted
using morpholinos that block splicing of a common conserved region of the transcripts located
between exon 8 (ex8D MO) and exon 9 (ex9A MO) (Figure S5A). These splice junction
morpholinos, referred to collectively as CstMO, abrogate proper splicing of both pre-mRNAs
and introduce a stop codon after the second amino acid following exon 8. CstMO, but not a
five-nucleotide mismatched CstMO, properly targets Cst until at least tadpole stage (Stage 42),
as shown by RT-PCR with the CstMO giving an amplified product that is larger than that in
control-MO-injected embryos by the size of the corresponding intron (679 bp) (Figure 1K).
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Cloning and sequencing of respective PCR bands confirmed that they were the expected
products derived from the Cst locus. Together, these data demonstrate that CstMO depletes
the embryo of CSTα and CSTβ until at least Stage 42.
Examination of CST-depleted embryos indicate that they are indistinguishable from control
MO-injected embryos until Stage 41 (Figures 1G–1J) when fluid begins to accumulate over
the dorsal fin and they have small, compact hearts (Figure 1J). Shortly thereafter (Stage 42),
CST-depleted embryos develop ventral edema (Figure S6) and die when sibling embryos
develop to Stage 46. Despite the normal appearance of earlier CST-depleted tadpole-stage
embryos (Stage 37) (Figures 1G–1H), upon closer examination, CST-depleted hearts had
improperly looped, giving the overall appearance of a twisted, kinked tube (Figure 1L) when
examined by MHC staining. Cst-specific morpholinos against the 5′ regions of Cstα and
Cstβ (Figure S5B) gave identical results, confirming that the phenotype is due to depletion of
CSTα and CSTβ. This strongly implies that any protein associated with the Cst splice junction
morpholinos is nonfunctional rather than acting as a dominant-negative protein. These data
demonstrate that CST is required for early cardiac development in Xenopus.
CST Is Required for the Onset of Cardiomyocyte Differentiation at the Ventral Midline
Since Cst is first expressed in heart primordium at Stage 27, the abnormal heart morphology
at tadpole Stage 37 is likely a consequence of an earlier requirement for CST in cardiac
development. During the process of early cardiogenesis, specified cardiac progenitor cells
migrate toward the ventral midline, where they meet (Stage 26) and fuse at the ventral midline
(Stage 29). Cardiomyocytes then undergo epithelialization, initiate the expression of cardiac
structural genes, and begin myofibrillogenesis. To determine when CST is required in heart
development, in situ analysis was performed on control and CST-depleted embryos with a
panel of early cardiac markers that include Nkx2.5, Tbx5, Tbx20, Gata4, Gata5, and Gata6.
No alteration in temporal or spatial expression of any of these markers was observed between
control and CST-depleted embryos up to Stage 29 (Figures 2A–2L; Figure S7), suggesting that
CST is not required for the determination, migration, or, most critically, fusion of cardiac
precursor cells.
To determine if CST is required for cardiomyocyte differentiation, whole-mount antibody
staining was conducted with antibodies against MHC (Figures 2M–2U) and Tropomyosin
(Tmy; Figures 2V–2Y). Although CST-depleted embryos have a single normal-sized
continuous cardiac field that uniformly expresses Nkx2.5, Tbx5, Tbx20, Gata4, Gata5, and
Gata6 (Figures 2A–2L; Figure S7), we found that CST-depleted embryos fail to initiate cardiac
differentiation at the ventral midline (Figures 2M–2O and 2V–2W). We confirmed that the
cells at the ventral midline are Nkx2.5 positive by double whole-mount in situ analysis with
Nkx2.5- and cardiac troponin I-specific probes (Figures 2Z–2B′). Additionally, we find CST-
depleted hearts have architectural defects including distention along the left-right axis in the
ventral region of the embryo (Figures 2N–2O and D′). These results collectively suggest that
CST is required within a 6 hr period of heart development between Stage 27 and Stage 29 for
proper differentiation of a subset of cardiomyocyte progenitors at the ventral midline.
To verify that alteration in heart morphology in CST-depleted embryos is associated with a
failure of ventral cardiomyocytes to undergo differentiation, we determined the total number
of differentiated cardiomyocytes in control and CST-depleted heart tissue staining with DAPI,
to mark cell nuclei, and anti-MHC, to mark differentiated cardiomyocytes (Figures 2C′–2E′).
Consistent with a failure of the ventral midline cells to express MHC, there is a significant
reduction in the number of terminally differentiated cardiomyocytes in CST-depleted hearts
relative to control hearts, 525.90 ± 42.16 versus 690.5 ± 19.76, respectively (Figure 2E′). We
further note that this decrease is not a reflection of a role for CST in cardiac cell survival since
we observed no increase in the total number of cardiac cells that were positive for TUNEL or
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the apoptotic marker Capase-3 during these stages (data not shown). Taken together, these data
demonstrate a role for CST in cardiac differentiation at the ventral midline and suggest that
regulation of cardiomyocyte differentiation is regionalized along the dorsal-ventral axis.
Failure of the cardiac cells in CST-depleted embryos to uniformly differentiate across the
ventral midline leads to a bifurcation of the developing linear heart tube by slightly later stages
(Stage 32) (Figures 2Q–2R and 2Y). Similar to genetic mutants in zebrafish which lead to
cardia bifida, e.g., natter, miles apart, mtx, and bon (Chen et al., 1996; Sakaguchi et al.,
2006; Stainier et al., 1996), severity of the bifida ranges from extreme phenotypes (30%
penetrance) (Figures 2R and 2Y), in which CST depletion results in two separate linear heart
tubes, to moderate phenotypes (60% penetrance) (Figure 2Q) that manifest as two heart fields
joined along the ventral mid-line either posteriorly or along the length of the heart field to form
an irregular heart tube. Variation in linear heart tube formation ultimately disrupts the
morphogenic movements of the heart tube, resulting in a secondary cardiac looping defect seen
in the chambered heart (Stage 37) (Figures 2T–2U). An identical cardiac phenotype is observed
when a combination of morpholinos targeting the 5′ UTR of Cstα and Cstβ is injected (Figure
S5C). Taken together, these results imply that, in contrast to other cardia bifida phenotypes,
CST depletion causes a bifurcation of the heart due to lack of uniform differentiation of
cardiomyocytes across the midline.
CST Depletion Does Not Affect Endoderm Formation or Patterning, Components of the
Extracellular Matrix, or Cardiac Polarity
Signals from the endoderm are required for proper cardiac midline development (Chen et al.,
1996; Stainier et al., 1996); however, we were unable to detect Cst expression within the
endoderm or endodermal derivatives over the periods in which we observed the phenotype in
CST-depleted embryos (Figure 1B; Figure S2). To further exclude the possibility that the
inability of cardiomyocytes to differentiate at the ventral midline in CST-depleted embryos is
a secondary consequence of alterations in the formation, maintenance, or patterning of
endodermal tissue, endodermal markers Endodermin, Sox2, Endocut, and Vito were assayed
for spatial expression by in situ analysis in both whole-mount and sectioned embryos, and for
quantitative expression by SYBR Green quantitative PCR (Figure 3). No alterations in spatial
or quantitative expression of any endodermal markers were observed in CST-depleted
embryos, further suggesting that CST is not required for the proper formation, maintenance,
or patterning of endodermal tissue.
To determine if CST functions in a tissue-autonomous fashion, we assayed for alteration in
components of the extracellular matrix (Fibronectin and Fibrillin), cardiomyocyte polarity (β-
Catenin), and endocardium/BMP signaling (SMAD1/5/8). No alteration in the staining pattern
of any of these markers was observed between control MO and CstMO-derived hearts (data
not shown). Collectively, these data demonstrate that the midline defect as a consequence of
CST depletion is due to a block or delay in cardiomyocyte differentiation and is not a secondary
consequence of alterations in cardiac migration or polarity. Moreover, these results suggest
that the phenotype of CST depletion is not associated with inappropriate activation of the
canonical Wnt pathway or inactivation of the BMP2/4/7 pathway.
Fate Mapping of Cardiac Ventral Midline Cells
Collectively, our results imply cardiomyocytes at the ventral mid-line have a fate different
from that of neighboring cardiomyocyte progenitors. To determine the ultimate fate of these
cardiomyocytes at the ventral midline, we conducted fate mapping studies at the time when
we first detect a phenotype in CST-depleted embryos; i.e., when cardiac progenitors have fused
at the anterior ventral midline (Stage 29). Using anatomical landmarks and a cardiac actin-GFP
(CA-GFP) transgenic reporter host strain of Xenopus to unambiguously identify cardiac tissue,
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we injected MitoTracker dye into the ventral midline of control MO-injected CA-GFP-positive
embryos (Figures 4A and 4B), identified by GFP expression in the developing somites. We
then scored embryos that incorporated the dye into the underlying mesoderm. Broadly
consistent with studies in chick (Abu-Issa and Kirby, 2007; De La Cruz et al., 1989; Moreno-
Rodriguez et al., 2006), we find that by the stage at which the heart initiates chamber
morphogenesis, cardiomyocytes derived from the ventral mid-line give rise to cells that occupy
positions in the medial outer curvature of the heart (Stage 35) (Figures 4C and 4E–4I). At later
stages, during the period after completion of chamber and valve formation (Stage 45), cells
preferentially colonize the outer curvature of the mature ventricle and, to a lesser extent, the
atrium (Figures 4D and 4V–4Z).
CST-Depleted Cardiac Ventral Midline Cells Fail to Integrate into the Mature Heart
To further establish the role of CST in cardiac midline development, and to confirm that cells
that occupy a position in cardiac ventral midline in CST-depleted embryos are cardiomyocyte
progenitors, we fate mapped ventral midline cells in CA-GFP embryos in which we depleted
CST. In stark contrast to results from wild-type embryos, ventral midline cells in CST-depleted
embryos preferentially give rise to cells that occupy positions in the posterior midline of the
developing heart (Figures 4D and 4J–4N). Interestingly, we also found a portion of fated CST-
depleted ventral midline cells located in a posterior undifferentiated ventricular cleft (Figures
4O–4U). Although we often observe that CST-depleted ventral midline cells are delayed but
not blocked in cardiomyocyte differentiation, in all case cells fail to integrate into the heart and
remain as a condensed population of cells attached to the outer ventricular wall (Figures 4D
and 4V–4Z).
CST Is Required for the Regulation of Cardiomyocyte Proliferation
We observe from our fate mapping studies at later stages that CST-depleted, labeled ventral
midline cells consistently give rise to a much larger population of cells relative to controls
(compare Figure 4Y with 4D′). Consistent with this observation, we find cardiomyocytes
undergoing differentiation in the more dorsal regions of the CST-depleted hearts have a
significantly increased mitotic index (Figure S8). Collectively, these data imply that CST plays
a critical role in regulating the proliferation and onset of differentiation of cardiac progenitors.
DISCUSSION
Our findings collectively imply that cardiomyocytes do not differentiate in a uniform manner
and strongly suggest that cells in the ventral region of the heart field differentiate in response
to localized signals. Our results further imply that cardiomyocytes differentiate along a dorsal-
ventral axis before the onset of terminal cardiomyocyte differentiation; thus, cardiac progenitor
fates appear to be determined prior to the formation of the linear heart tube.
We observe that the requirement for CST in cardiomyocyte differentiation is within a subset
of cardiac progenitor cells in which Cst is expressed. What then limits CST function to the
ventral midline? One possibility is that CST functions redundantly with other transcription
factors in regulating cardiomyocyte differentiation in more dorsal regions of the heart;
however, CST binds DNA through a unique para-zinc finger domain (Mellerick et al., 1992).
Similar to studies in Drosophila, we are unable to identify any protein in the genomes of
Xenopus, chick, or mammals that contains a similar domain, suggesting that CST acts on an
exclusive set of transcriptional targets. Based on these observations, our phenotypic analysis
of cardiac tissue depleted of CST, and by inference with Drosophila (Kambadur et al., 1998),
we hypothesize that Cst activity is regulated by as yet unidentified factors. Consistent with this
proposal, we have shown that overexpression of CST throughout the embryo leads to cellular
defects only in tissue types that normally express CST (data not shown).
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We note that our fate mapping studies of early Xenopus hearts are consistent with those
performed in chick showing that cardiac progenitors at the ventral midline preferentially give
rise to terminally differentiated cardiomyocytes in the outer ventricular wall (De La Cruz et
al., 1989; Moreno-Rodriguez et al., 2006). Studies in chick further demonstrated that
cardiomyocyte progenitors at the ventral midline are derived from the cephalic mesoderm; i.e.,
the anterior heart field. Therefore, it is intriguing to speculate that the regulation of CST activity
restricts its role to cardiac cells derived from the anterior heart field.
In light of the role for CST in cardiac differentiation and its high degree of sequence
conservation and expression between vertebrates (Liu et al., 2006; Vacalla and Theil, 2002),
it will be interesting in the future to examine the relationship between CST and congenital heart
disease and cardiac hypertrophy.
EXPERIMENTAL PROCEDURES
Embryo Collection, Cst Cloning, and Morpholinos
Preparation and collection of X. tropicalis and X. laevis were performed as described (Showell
et al., 2006) and staged according to Nieuwkoop and Faber (1967). Cst-specific morpholinos
were obtained from Gene Tools, LLC. Sequences of all morpholinos are available upon request.
To demonstrate morpholino efficacy, RNA was extracted from homogenized Stage 42 tadpoles
in lysis buffer (Goetz et al., 2006) followed by RT-PCR as described in Supplemental
Experimental Procedures.
Developmental Whole-Mount In Situ Hybridization
Whole-mount in situ analysis and double detection whole-mount in situ analysis was carried
out as described (Harland, 1991) using α-sense RNA probes of Nkx2.5 (Tonissen et al.,
1994), Tbx5 (Horb and Thomsen, 1999), Tbx20 (Brown et al., 2003), cardiac troponin I (Logan
and Mohun, 1993), Sox2 (Kishi et al., 2000), Endodermin (Langdon et al., 2007), Endocut
(Costa et al., 2003), and Vito (Xenopus EST clone XL043k17 [Costa et al., 2003]). For double
in situs the protocol was modified so embryos were simultaneously analyzed with fluorosceine-
labeled Nkx2.5 probe and either Cst or cardiac troponin I DIG-labeled probe. Following
incubation with α-fluorosceine alkaline phosphatase antibody, Nkx2.5 expression was detected
using 175 μg/ml of magenta phosphate and 225 μg/ml tetrazolium red in AP buffer at 4°C for
3–5 days. Embryos were washed three times in PBS incubated in 0.1 M glycine-HCl (pH 2.2),
0.1% Tween-20 for 10 min at RT. DIG-labeled probes were detected as described. Embryos
were bleached then photographed on a Leica MZF III fluorescent dissecting microscope.
Stained embryos were prepared for 20 μm frozen sectioning in OTC freezing media. Sections
were rinsed with PBS, coverslipped, and imaged on a Zeiss Axiovert 35 microscope.
Immunohistochemistry
Immunohistochemistry was carried out with mouse anti-Myosin Heavy Chain, mouse anti-
Tropomyosin (Developmental Studies Hybridoma Bank), and rabbit anti-phospho-histone H3
(Cell Signaling) using Cy3 anti-rabbit, Cy3 anti-mouse, and Alexa 488 anti-mouse as described
(Goetz et al., 2006). Embryos were cleared in 2:1 benzyl benzoate:benzyl alcohol and viewed
on a Leica MZFIII fluorescence dissecting microscope. Sections were imaged on a Nikon
Eclipse E800 fluorescent microscope.
SYBR Green Quantitative PCR
RNA was isolated from Stage 29 embryos (ten embryos per condition) using Trizol (Invitrogen)
and purified using an RNeasy column (QIAGEN) according to the manufacture’s protocol.
cDNA synthesis with 1 μg of RNA was performed with random primers using SuperScript II
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reverse transcriptase (Invitrogen) according to the manufacture’s protocol. Expression levels
were assessed by quantitative PCR using SYBR Green Master Mix (Sigma) on a Rotogene
3000. Primers (19–21 bp) were designed for each mRNA to amplify a 100–121 bp product.
Prior to quantitative PCR analysis, primer sets were tested by standard PCR and analyzed by
2.5% agarose gel electrophoresis to determine amplification of a single PCR product. GAPDH
was used as the housekeeping gene. Reactions with 5 μl of a 1:60 dilution of the cDNA were
heated to 94° for 2 min, followed by 50 cycles of 94°C, 15 s; 55°C, 15 s; 72°C, 20 s. Following
amplification, melting curves were generated to verify the presence of a single amplification
product. Each sample was analyzed in triplicate with a corresponding minus-RT control. Five
samples (n = 5) per condition were analyzed. Analysis generated Ct values based on thresholds
determined by Rotogene 3000 software. Data were analyzed by the Pfaffl method (Pfaffl et
al., 2002) and represented as relative fold change ± SEM.
Fate Mapping
Fertilized embryos were injected at the one-cell stage with either Cst MOs or control MOs as
described (Goetz et al., 2006). Stage 29 GFP-positive embryos were embedded in 3% methyl-
cellulose and injected with 0.3 nl of 1 mM Mito Tracker Red CMXRos (Molecular Probes) at
the ventral midline 5.5 mm from the posterior boundary of the cement gland. Two hours
postinjection, embryos were analyzed and scored for incorporation into GFP-positive cardiac
tissue. Stage 35 and 45 hearts were dissected in 1 × Modified Barths Solution (MBS) and placed
in 1 × MBS supplemented with 0.1 M KCl to arrest contraction. Stage 35 labeled clones were
scored based on anterior-posterior axis and inner-outer curvature of the heart, and Stage 45
based on location of labeled clones in the atrium or ventricle. Transgenic animals expressing
cardiac actin-GFP were a generous gift from Dr. Tim Mohun (Latinkic et al., 2002).
Statistical Methods
Morpholino injections were performed on >15 batches of embryos. Similar results were seen
in each experiment. Statistical differences of cell counts between injected embryos were
determined using one-tailed, unpaired t tests. The number of embryos used in each experiment
is noted in the results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CST Is Required for Vertebrate Heart Development
(A) Predicted schematic representation of CSTα and CSTβ proteins; nuclear localization signal
(yellow), zinc finger repeats (red), serine-rich region (red).
(B–F) Whole-mount in situ analysis of Stage 27 (early tailbud), Stage 32 (tailbud), and Stage
36 (early tadpole) embryos using a Cst-specific probe common to Cstα and Cstβ. ([B], lateral
view with anterior to the left; [C and D] ventral and dorsal views, respectively, with anterior
to the top). (D and F) Transverse sections of whole-mount in situ Stage 36 embryos through
(D) the heart and (F) the hindbrain: hindbrain (hb), somites (s), heart primordium (hp), heart
(h), myocardium (m), endocardium (en), commissural neurons (c).
(G–J) Representative (G and I) control MO and (H and J) CstMO embryos. (G) Stage 32 control
MO and (H) CstMO embryos are indistinguishable. (I) Stage 41 control MO and (J) CstMO
embryos. CST-depleted embryos present with dorsal fin edema and no gross ventral region
abnormalities.
(K) RT-PCR analysis of Stage 42 tadpoles injected at the one-cell stage with the CstMO
demonstrating inhibition of proper slicing of Cst pre-mRNA. Control MO (Con MO) and 5-
mismatch MO (5-mis MO) are negative controls.
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(L) Whole-mount MHC antibody staining of tadpole Stage 37 CST-depleted embryos (lateral
views with anterior to the left); inflow tract (i), ventricle (v), outflow tract (o). Scale bars: (B–
C) = 0.5 mm, (G) = 1 mm, (D and L) = 100 μm.
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Figure 2. CST Is Required for Cardiomyocyte Differentiation at the Ventral Midline
(A–L) Whole-mount in situ analysis with early cardiac markers Nkx2.5 (A, B, G, and H),
Tbx5 (C, D, I, and J), and Tbx20 (E, F, K, and L) of tailbud Stage 26 and 29 control and CST-
depleted embryos (ventral view with anterior to the top). Cardiac progenitors have properly
migrated and completely fused across the ventral midline.
(M–U) Whole-mount MHC antibody staining at Stage 29 (onset of cardiac differentiation),
Stage 32 (completion of linear heart tube formation), and Stage 37 (chamber formation) (ventral
view with anterior to the top). (M) Stage 29 control MO embryos and (N and O) CST-depleted
embryos. (P) Stage 32 control MO embryos and (Q and R) CST-depleted embryos display
varying degrees of cardia bifida of the linear heart tube upon CST depletion. (S) Stage 37
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control MO embryos and (T and U) CST-depleted embryos display morphological
consequences of CST depletion on chamber formation.
(V–Y) Whole-mount Tmy antibody staining of Stage 29 and 32 (V and X) control MO and (W
and Y) CST-depleted embryos demonstrates that lack of differentiation is not specific to MHC.
(Z–B′) Simultaneous detection of cardiac progenitor cells and differentiated cardiac cells in a
Stage 29 CST-depleted embryo.
(Z and A′) Whole-mount double in situ analysis using a Nkx2.5-specific probe (pink) to mark
cardiac progenitor cells and Cardiac troponin I-specific probe (blue) to mark differentiated
cardiac cells in (Z) control MO and (A′) CST-depleted embryos.
(B′) Magnified image of the cardiac region in the CST-depleted embryo in (A′).
(C′ and D′) Transverse sections of Stage 29 (C′) control MO and (D′) CST-depleted embryos
stained with MHC antibody and DAPI. Brackets highlight the lack of differentiation at the
ventral midline.
(E′) Quantification of differentiated cardiomyocytes determined by counting the total MHC-
positive cells derived from serial sectioned embryos. Bars represent the average of at least six
embryos per condition ± SEM; *p < 0.01. Representative images are derived from a single
experiment, and all experiments were repeated at least twice with independent batches of
embryos. Scale bars: (G) = 0.5 mm, (S and X) = 100 μm, (C′) = 200 μm.
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Figure 3. CST Is Not Required for Formation or Patterning of Endodermal Tissue
(A) Schematic representation of endodermal tissue markers that demarcate pharyngeal
endoderm (Sox2 and Endodermin), ventral midgut (Vito and Endodermin), and posterior
endoderm (Endocut).
(B) Relative expression levels of endodermal markers Sox2, Vito, Endodermin, and Endocut
in Stage 29 CST-depleted embryos (n = 5) relative to control MO embryos (n = 5) using
GAPDH as the housekeeping gene. Bars represent the relative expression levels ± SEM.
(C–F) Whole-mount in situ analysis of endodermal markers (C) Sox2, (D) Vito, (E)
Endodermin, and (F) Endocut in Stage 29 (top) control MO and (bottom) CST-depleted
embryos (lateral views with anterior to the left).
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(G–H) In situ analysis of endodermal and cardiac markers on adjacent transverse sections
through the cardiac region of (top) control MO and (bottom) CST-depleted Stage 29 embryos.
(G) Sox2 and Nkx2.5 expression on adjacent sections demonstrating proper expression within
pharyngeal tissue of CST-depleted embryos. (H) Endodermin and Tbx20 expression on
adjacent sections demonstrating proper relative spatial expression within the cardiac tissue and
endoderm of the embryo.
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Figure 4. Fate Mapping Cardiac Ventral Midline Cells
(A) Bright-field image of a living cardiac actin-GFP transgenic embryo injected with
MitoTracker at Stage 29 along the ventral midline 5.5 mm posterior to the cement gland (CG).
(B) Fluorescent image of the same embryo demonstrating the location of incorporated
MitoTracker into cells at the ventral midline (ventral views with anterior to the top).
Fluorescence anterior to site of injection is reflection off the surface of the live embryo. (C and
D) Tabulation of the location of MitoTracker-labeled cardiac cells of control MO and CST-
depleted embryo at (C) midtailbud Stage 35 and (D) tadpole Stage 45. Images of CA-GFP
transgenic control MO-injected and CST-depleted (E–H, J–M, and O–U) Stage 35 and (V–Y
and A′–D′) Stage 45 dissected hearts. (F, K, P, T, U, and Z) Corresponding images of GFP
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expression. (G, L, Q, X, and C′) Corresponding images of fated MitoTracker-labeled cardiac
ventral midline cells. (H, M, R, U, Y, and D′) Merged images of GFP and fated MitoTracker-
labeled ventral midline cells. (T and U) Note the fated ventral midline cells in a pocket of
undifferentiated (GFP-negative) cardiomyocytes. (I, N, S, Z, and E′) Schematics representing
fate of the cardiac ventral midline cells to the outer curvature of the ventricle in (I) Stage 35
and (Z) Stage 45 control MO-injected hearts. CST-depleted fated ventral midline cells located
in the (N) posterior midline or (S) in an undifferentiated cleft in the outer ventricular
myocardium in Stage 35 CST-depleted hearts and (E′) in a condensed mass of cells on the outer
ventricle in Stage 45 CST-depleted hearts.
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